Trinity Biotech (TRIB)
NASDAQ: TRIB
· Real-Time Price · USD
1.63
-0.28 (-14.66%)
At close: Aug 15, 2025, 3:59 PM
1.48
-9.20%
After-hours: Aug 15, 2025, 07:58 PM EDT
-14.66% (1D)
| Bid | 1.39 |
| Market Cap | 16.93M |
| Revenue (ttm) | 61.56M |
| Net Income (ttm) | -31.79M |
| EPS (ttm) | -1.8 |
| PE Ratio (ttm) | -0.91 |
| Forward PE | -0.84 |
| Analyst | n/a |
| Ask | 1.55 |
| Volume | 3,856,325 |
| Avg. Volume (20D) | 4,382,635 |
| Open | 1.64 |
| Previous Close | 1.91 |
| Day's Range | 1.38 - 1.75 |
| 52-Week Range | 0.48 - 3.44 |
| Beta | 0.77 |
About TRIB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRIB
Website n/a
Next Earnings Release
Trinity Biotech is scheduled to release its earnings on
Aug 26, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 day ago
+89.11%
Trinity Biotech shares are trading higher after th...
Unlock content with
Pro Subscription
3 days ago
+35.59%
Trinity Biotech shares are trading higher after the company announced its clinical trial results demonstrating a major technical breakthrough and de-risking the commercial pathway for its next-generation continuous glucose monitoring technology, called CGM+.
